Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1971 1
1972 5
1973 6
1974 5
1975 5
1976 3
1977 4
1978 1
1979 4
1982 2
1983 4
1984 3
1986 2
1987 7
1988 3
1989 7
1990 5
1991 5
1992 2
1993 4
1994 4
1995 2
1996 5
1997 4
1998 2
1999 1
2000 4
2001 4
2002 2
2003 3
2004 3
2006 4
2007 4
2008 1
2010 1
2013 1
2014 1
2015 1
2016 1
2018 1
2020 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Results by year

Filters applied: . Clear all
Page 1
Benztropine and suicide attempts and intentional self-harm.
Gibbons RD, Hur K, Lavigne JE, Mann JJ. Gibbons RD, et al. Psychiatry Res. 2023 Feb;320:115054. doi: 10.1016/j.psychres.2023.115054. Epub 2023 Jan 7. Psychiatry Res. 2023. PMID: 36638693 Clinical Trial.
BACKGROUND: This large-scale pharmacoepidemiologic study was conducted to confirm a previous signal for decreased risk of suicide attempt following prescription fills for benztropine. METHODS: We used a within-person exposure-only cohort design to study the dynamic associa …
BACKGROUND: This large-scale pharmacoepidemiologic study was conducted to confirm a previous signal for decreased risk of suicide attempt fo …
The effect of benztropine on haloperidol-induced dystonia, clinical efficacy and pharmacokinetics: a prospective, double-blind trial.
Goff DC, Arana GW, Greenblatt DJ, Dupont R, Ornsteen M, Harmatz JS, Shader RI. Goff DC, et al. J Clin Psychopharmacol. 1991 Apr;11(2):106-12. J Clin Psychopharmacol. 1991. PMID: 2056136 Clinical Trial.
Twenty-nine inpatients with major psychotic disorders were treated for 14 days with a clinician-determined dose of haloperidol and with either benztropine or placebo given by double-blind random assignment on days 1 through 7. No differences were noted in haloperidol mean …
Twenty-nine inpatients with major psychotic disorders were treated for 14 days with a clinician-determined dose of haloperidol and with eith …
Treatment of valproate tremors.
Karas BJ, Wilder BJ, Hammond EJ, Bauman AW. Karas BJ, et al. Neurology. 1983 Oct;33(10):1380-2. doi: 10.1212/wnl.33.10.1380. Neurology. 1983. PMID: 6412157 Clinical Trial.
We studied the effects of propranolol, amantadine, diphenhydramine, benztropine, and cyproheptadine on these tremors in 19 patients by using serial accelerometric recordings. ...Amantadine was moderately effective, but cyproheptadine, diphenhydramine, and benztropine …
We studied the effects of propranolol, amantadine, diphenhydramine, benztropine, and cyproheptadine on these tremors in 19 patients b …
Benztropine for the relief of acute non-traumatic neck pain (wry neck): a randomised trial.
Asha SE, Kerr A, Jones K, McAlpine A. Asha SE, et al. Emerg Med J. 2015 Aug;32(8):616-9. doi: 10.1136/emermed-2014-204317. Epub 2014 Nov 20. Emerg Med J. 2015. PMID: 25414475 Clinical Trial.
RESULTS: Thirty participants were enrolled, 15 randomised to placebo and 15 to benztropine. Pain scores at 30 min were lower in those allocated to benztropine, but the difference was neither statistically nor clinically significant (0.6 points, 95% CI -0.8 to 1.8, p …
RESULTS: Thirty participants were enrolled, 15 randomised to placebo and 15 to benztropine. Pain scores at 30 min were lower in those …
Pharmacological characterization of tardive dyskinesia.
Casey DE, Denney D. Casey DE, et al. Psychopharmacology (Berl). 1977 Aug 31;54(1):1-8. doi: 10.1007/BF00426532. Psychopharmacology (Berl). 1977. PMID: 410053 Clinical Trial.
Six patients were evaluated with single challenge doses of a DA agonist, levodopa, and antagonist, droperidol, as well as with an ACh agonist, physostigmine, an antagonist, benztropine, and a placebo. A single blind trial with deanol and placebo followed. Responses, measur …
Six patients were evaluated with single challenge doses of a DA agonist, levodopa, and antagonist, droperidol, as well as with an ACh agonis …
Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.
Rosenheck R, Perlick D, Bingham S, Liu-Mares W, Collins J, Warren S, Leslie D, Allan E, Campbell EC, Caroff S, Corwin J, Davis L, Douyon R, Dunn L, Evans D, Frecska E, Grabowski J, Graeber D, Herz L, Kwon K, Lawson W, Mena F, Sheikh J, Smelson D, Smith-Gamble V; Department of Veterans Affairs Cooperative Study Group on the Cost-Effectiveness of Olanzapine. Rosenheck R, et al. JAMA. 2003 Nov 26;290(20):2693-702. doi: 10.1001/jama.290.20.2693. JAMA. 2003. PMID: 14645311 Clinical Trial.
INTERVENTIONS: Patients were randomly assigned to receive flexibly dosed olanzapine, 5 to 20 mg/d, with prophylactic benztropine, 1 to 4 mg/d (n = 159); or haloperidol, 5 to 20 mg/d (n = 150), for 12 months. ...CONCLUSION: Olanzapine does not demonstrate advantages compare …
INTERVENTIONS: Patients were randomly assigned to receive flexibly dosed olanzapine, 5 to 20 mg/d, with prophylactic benztropine, 1 t …
A randomized placebo-controlled trial of desipramine, cognitive behavioral therapy, and active placebo therapy for low back pain.
Gould HM, Atkinson JH, Chircop-Rollick T, D'Andrea J, Garfin S, Patel SM, Funk SD, Capparelli EV, Penzien DB, Wallace M, Weickgenanta AL, Slater M, Rutledge T. Gould HM, et al. Pain. 2020 Jun;161(6):1341-1349. doi: 10.1097/j.pain.0000000000001834. Pain. 2020. PMID: 32068667 Clinical Trial.
Participants (n = 142) were patients experiencing daily chronic back pain at an intensity of 4/10 who were randomized to a single-center, double-blind, 12-week, 4-arm, parallel groups controlled clinical trial of (1) low concentration desipramine titrated to reach a serum concent …
Participants (n = 142) were patients experiencing daily chronic back pain at an intensity of 4/10 who were randomized to a single-center, do …
Ethopropazine and benztropine in neuroleptic-induced parkinsonism.
Chouinard G, Annable L, Ross-Chouinard A, Kropsky ML. Chouinard G, et al. J Clin Psychiatry. 1979 Mar;40(3):147-52. J Clin Psychiatry. 1979. PMID: 33969 Clinical Trial.
In a 12-week controlled study ethopropazine was compared to benztropine in the treatment of parkinsonism induced by fluphenazine enanthate in 60 schizophrenic outpatients. Ethopropazine and benztropine were found to be equally effective in controlling parkinsonian s …
In a 12-week controlled study ethopropazine was compared to benztropine in the treatment of parkinsonism induced by fluphenazine enan …
Efficacy of benztropine therapy for drooling.
Camp-Bruno JA, Winsberg BG, Green-Parsons AR, Abrams JP. Camp-Bruno JA, et al. Dev Med Child Neurol. 1989 Jun;31(3):309-19. doi: 10.1111/j.1469-8749.1989.tb04000.x. Dev Med Child Neurol. 1989. PMID: 2666205 Clinical Trial.
This study assessed the efficacy of synthetic anticholinergic benztropine and incidence of side-effects in 20 developmentally-disabled patients with severe drooling. The double-blind, placebo-controlled, crossover protocol included one-week baseline, two-week placebo and t …
This study assessed the efficacy of synthetic anticholinergic benztropine and incidence of side-effects in 20 developmentally-disable …
Efficacy of Low-Dose Amitriptyline for Chronic Low Back Pain: A Randomized Clinical Trial.
Urquhart DM, Wluka AE, van Tulder M, Heritier S, Forbes A, Fong C, Wang Y, Sim MR, Gibson SJ, Arnold C, Cicuttini FM. Urquhart DM, et al. JAMA Intern Med. 2018 Nov 1;178(11):1474-1481. doi: 10.1001/jamainternmed.2018.4222. JAMA Intern Med. 2018. PMID: 30285054 Free PMC article. Clinical Trial.
INTERVENTION: Low-dose amitriptyline (25 mg/d) or an active comparator (benztropine mesylate, 1 mg/d) for 6 months. MAIN OUTCOMES AND MEASURES: The primary outcome was pain intensity measured at 3 and 6 months using the visual analog scale and Descriptor Differential Scale …
INTERVENTION: Low-dose amitriptyline (25 mg/d) or an active comparator (benztropine mesylate, 1 mg/d) for 6 months. MAIN OUTCOMES AND …
127 results